Results for tag: "Trypanosomiasis Drug"

Trypanosomiasis is a parasitic disease caused by the protozoan Trypanosoma. It is transmitted by the bite of an infected tsetse fly and is found in sub-Saharan Africa. Treatment of the disease is mainly through the use of drugs, such as pentamidine, suramin, melarsoprol, eflornithine, and nifurtimox. These drugs are used to treat both the acute and chronic forms of the disease. The Trypanosomiasis Drug market is a niche market, with a limited number of drugs available for treatment. The drugs are mainly used in sub-Saharan Africa, where the disease is most prevalent. The market is highly competitive, with a few major players dominating the market. Some of the companies in the Trypanosomiasis Drug market include GlaxoSmithKline, Sanofi, Merck, Pfizer, and Novartis. Show Less Read more